Skip to main content
Tuya Pal, MD, Medical Genetics, Nashville, TN

Tuya Pal MD

Clinical Genetics


Professor of Medicine (Genetic Medicine), Vanderbilt University Medical Center; Ingram Professor of Cancer Research, Associate Director of Cancer Health Disparities, Vanderbilt-Ingram Cancer Center

Join to View Full Profile
  • 3601 The Vanderbilt ClinicNashville, TN 37232

  • Phone+1 615-936-2000

Dr. Pal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1992 - 1995
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1992

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2002 - 2026
  • TN State Medical License
    TN State Medical License 2017 - 2026
  • AL State Medical License
    AL State Medical License 2020 - 2020
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Clinical Genetics and Genomics
    American Board of Medical Genetics and Genomics Clinical Genetics and Genomics

Publications & Presentations

PubMed

Press Mentions

  • Study in Multiancestry Populations Uncovers New Insights into Breast Cancer Genetics
    Study in Multiancestry Populations Uncovers New Insights into Breast Cancer GeneticsJanuary 15th, 2025
  • Worldwide Experts Release Clinical Recommendations for Management of ATM Cancer Risk
    Worldwide Experts Release Clinical Recommendations for Management of ATM Cancer RiskJanuary 8th, 2025
  • Study Identifies That Higher West African Ancestry May Contribute to Worse Breast Cancer Outcomes
    Study Identifies That Higher West African Ancestry May Contribute to Worse Breast Cancer OutcomesDecember 10th, 2024
  • Join now to see all

Grant Support

  • CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the LifespanVANDERBILT UNIVERSITY MEDICAL CENTER2021–2027
  • CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the LifespanVANDERBILT UNIVERSITY MEDICAL CENTER2021–2027
  • Disparities in breast cancer treatment using Granulocyte colony-stimulating factors and CDK4/6 inhibitors between African and European ancestry individuals in two large Electronic Health RecordsVANDERBILT UNIVERSITY MEDICAL CENTER2011–2026
  • Disparities in breast cancer treatment using Granulocyte colony-stimulating factors and CDK4/6 inhibitors between African and European ancestry individuals in two large Electronic Health RecordsVANDERBILT UNIVERSITY MEDICAL CENTER2011–2026
  • Disparities in breast cancer treatment using Granulocyte colony-stimulating factors and CDK4/6 inhibitors between African and European ancestry individuals in two large Electronic Health RecordsVANDERBILT UNIVERSITY MEDICAL CENTER2011–2026
  • Disparities in breast cancer treatment using Granulocyte colony-stimulating factors and CDK4/6 inhibitors between African and European ancestry individuals in two large Electronic Health RecordsVANDERBILT UNIVERSITY MEDICAL CENTER2011–2026
  • (2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer DisparitiesVANDERBILT UNIVERSITY MEDICAL CENTER2011–2026
  • (2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer DisparitiesVANDERBILT UNIVERSITY MEDICAL CENTER2011–2026
  • (2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer DisparitiesVANDERBILT UNIVERSITY MEDICAL CENTER2011–2026
  • (2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer DisparitiesVANDERBILT UNIVERSITY MEDICAL CENTER2011–2026
  • Disparities in breast cancer treatment using Granulocyte colony-stimulating factors and CDK4/6 inhibitors between African and European ancestry individuals in two large Electronic Health RecordsVANDERBILT UNIVERSITY MEDICAL CENTER2011–2026
  • IMProving Care After Inherited Cancer Testing (IMPACT) StudyVANDERBILT UNIVERSITY MEDICAL CENTER2020–2025
  • IMProving Care After Inherited Cancer Testing (IMPACT) StudyVANDERBILT UNIVERSITY MEDICAL CENTER2020–2025
  • Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)VANDERBILT UNIVERSITY MEDICAL CENTER2019–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: